Literature DB >> 2492278

Comparison of variable region primary structures within an anti-fluorescein idiotype family.

W D Bedzyk1, L S Johnson, G S Riordan, E W Voss.   

Abstract

Previous reports described the properties of a high affinity (Ka = 1.7 X 10(10) M-1) prototype anti-fluorescein monoclonal antibody 4-4-20, an intermediate affinity (Ka = 3.7 X 10(7) M-1) prototype 9-40, and Ig members of the 9-40 idiotype family (comprised of 3-24, 5-14, 5-27, 10-25 and 12-40). Although the seven monoclonal anti-fluorescein antibodies expressed similar active site structural determinants (idiotypes) as determined serologically, each was characterized by different affinities for fluorescein and fine specificity binding patterns. Partial heavy (H)- and light (L)-chain N-terminal amino acid sequence analyses revealed all antibodies (except 5-27) were composed of highly homologous VHIII(C) and V kappa II subgroup genes, respectively. Antibody 5-27 utilized a VHIII(B) and a V kappa V subgroup genes and shared low V-region sequence homology with 4-4-20, 9-40 and the remaining 9-40 idiotype family. In addition, complete 4-4-20, VH- and VL-region primary structures were determined to better understand antibody-antigen interactions. Antibody 4-4-20 utilized a VHIII(C) subgroup VH-gene, a truncated Sp2 D gene segment, JH4, a V kappa II subgroup VL-gene, and J kappa 1. Antibody 4-4-20 VH and VL complementarity-determining regions contained many basic and aromatic amino acid residues capable of interaction with fluorescein. Results are discussed in terms of idiotypic and fluorescein-binding characteristics as well as antibody structural and functional diversity in the immune response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  How well can an idiotope peptide mimic replace its parent idiotype in a synthetic peptide vaccine?

Authors:  James S Cavenaugh; Hsu-kun Wang; Jiang Sha; Corey Hansen; Kongnara Papangkorn; Richard S Smith; James N Herron
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Lupus-derived autoantibodies with dual autoactivity: anti-DNA and anti-Fc. II. Fine specificity of anti-self autoreactivity.

Authors:  C A Rumbley; E W Voss
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

3.  A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.

Authors:  H Miyashita; T Hara; R Tanimura; F Tanaka; M Kikuchi; I Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

4.  Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.

Authors:  Matthew R Vogt; Kimberly A Dowd; Michael Engle; Robert B Tesh; Syd Johnson; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

5.  Human monoclonal antibodies with different fine specificity for digoxin derivatives: cloning of heavy and light chain variable region sequences.

Authors:  L Danielsson; C Furebring; M Ohlin; L Hultman; M Abrahamson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

6.  High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity.

Authors:  J N Herron; A H Terry; S Johnston; X M He; L W Guddat; E W Voss; A B Edmundson
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

7.  Fluorescence measurements of immune complexes of Mab 4-4-20 with isomeric haptens.

Authors:  C A Swindlehurst; E W Voss
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

8.  Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations.

Authors:  M Ahlers; D W Grainger; J N Herron; K Lim; H Ringsdorf; C Salesse
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.